404 related articles for article (PubMed ID: 24629717)
1. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
Glück L; Loktev A; Moulédous L; Mollereau C; Law PY; Schulz S
Biol Psychiatry; 2014 Nov; 76(10):767-74. PubMed ID: 24629717
[TBL] [Abstract][Full Text] [Related]
2. Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
Grecksch G; Just S; Pierstorff C; Imhof AK; Glück L; Doll C; Lupp A; Becker A; Koch T; Stumm R; Höllt V; Schulz S
J Neurosci; 2011 Sep; 31(39):13890-6. PubMed ID: 21957251
[TBL] [Abstract][Full Text] [Related]
3. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
Kovoor A; Celver JP; Wu A; Chavkin C
Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514
[TBL] [Abstract][Full Text] [Related]
4. Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms.
Kuhar JR; Bedini A; Melief EJ; Chiu YC; Striegel HN; Chavkin C
Cell Signal; 2015 Sep; 27(9):1799-806. PubMed ID: 26056051
[TBL] [Abstract][Full Text] [Related]
5. Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo.
Kibaly C; Lin HY; Loh HH; Law PY
Pharmacol Res; 2017 May; 119():153-168. PubMed ID: 28179123
[TBL] [Abstract][Full Text] [Related]
6. G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.
Terman GW; Jin W; Cheong YP; Lowe J; Caron MG; Lefkowitz RJ; Chavkin C
Br J Pharmacol; 2004 Jan; 141(1):55-64. PubMed ID: 14662727
[TBL] [Abstract][Full Text] [Related]
7. T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.
Wang XF; Barbier E; Chiu YT; He Y; Zhan J; Bi GH; Zhang HY; Feng B; Liu-Chen LY; Wang JB; Xi ZX
J Neurosci; 2016 Oct; 36(40):10392-10403. PubMed ID: 27707973
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid CB
Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
Chen SL; Ma HI; Han JM; Lu RB; Tao PL; Law PY; Loh HH
J Biomed Sci; 2010 Apr; 17(1):28. PubMed ID: 20403204
[TBL] [Abstract][Full Text] [Related]
10. Morphine-induced antinociception and reward in "humanized" mice expressing the mu opioid receptor A118G polymorphism.
Henderson-Redmond AN; Yuill MB; Lowe TE; Kline AM; Zee ML; Guindon J; Morgan DJ
Brain Res Bull; 2016 May; 123():5-12. PubMed ID: 26521067
[TBL] [Abstract][Full Text] [Related]
11. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
12. Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6.
Raehal KM; Schmid CL; Medvedev IO; Gainetdinov RR; Premont RT; Bohn LM
Drug Alcohol Depend; 2009 Oct; 104(3):187-96. PubMed ID: 19497686
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
[TBL] [Abstract][Full Text] [Related]
14. Role of the guanine nucleotide binding protein, Gα
Lamberts JT; Rosenthal LD; Jutkiewicz EM; Traynor JR
Psychopharmacology (Berl); 2018 Jan; 235(1):71-82. PubMed ID: 28971229
[TBL] [Abstract][Full Text] [Related]
15. Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons.
Macey TA; Lowe JD; Chavkin C
J Biol Chem; 2006 Nov; 281(45):34515-24. PubMed ID: 16982618
[TBL] [Abstract][Full Text] [Related]
16. The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.
Petraschka M; Li S; Gilbert TL; Westenbroek RE; Bruchas MR; Schreiber S; Lowe J; Low MJ; Pintar JE; Chavkin C
Neuroscience; 2007 Jun; 146(4):1795-807. PubMed ID: 17467916
[TBL] [Abstract][Full Text] [Related]
17. Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.
Doll C; Pöll F; Peuker K; Loktev A; Glück L; Schulz S
Br J Pharmacol; 2012 Nov; 167(6):1259-70. PubMed ID: 22725608
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
19. The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.
Anand JP; Boyer BT; Mosberg HI; Jutkiewicz EM
Psychopharmacology (Berl); 2016 Jul; 233(13):2479-87. PubMed ID: 27117141
[TBL] [Abstract][Full Text] [Related]
20. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
